title: The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise.
mesh_terms: D016915:AIDS Vaccines / Q000191:economics / Q000627:therapeutic use*; D035843:Biomedical Research / Q000592:standards; D002986:Clinical Trials as Topic; D015195:Drug Design; D014943:Global Health; D015658:HIV Infections / Q000235:genetics / Q000276:immunology* / Q000517:prevention & control; D006295:Health Resources / Q000191:economics / Q000458:organization & administration; D006801:Humans; D007221:Industry
chemical_list: D016915:AIDS Vaccines
references.citation: J Exp Med. 2008 Dec 22;205(13):3119-31
references.pmid: 19047440
references.citation: Science. 2010 Jun 11;328(5984):1359-60
references.pmid: 20538936
references.citation: PLoS Med. 2005 Feb;2(2):e25
references.pmid: 15740411
references.citation: Nat Med. 2009 Mar;15(3):293-9
references.pmid: 19219024
references.citation: Lancet. 2007 Nov 17;370(9600):1665
references.pmid: 18022020
references.citation: AIDS. 2009 Jan 2;23(1):3-8
references.pmid: 19050380
references.citation: Nat Rev Immunol. 2010 Jan;10(1):11-23
references.pmid: 20010788
references.citation: Immunity. 2008 Dec 19;29(6):835-8
references.pmid: 19100694
references.citation: Curr Opin HIV AIDS. 2009 Sep;4(5):431-40
references.pmid: 20048708
references.citation: Nature. 2007 Sep 6;449(7158):101-4
references.pmid: 17805298
references.citation: Nat Med. 2007 Jan;13(1):100-6
references.pmid: 17187074
references.citation: Nature. 2010 Mar 11;464(7286):217-23
references.pmid: 20220840
references.citation: Science. 2003 Jun 27;300(5628):2036-9
references.pmid: 12829768
references.citation: J Virol. 2010 Jul;84(14):7161-73
references.pmid: 20444898
references.citation: AIDS. 2010 May 15;24(8):1095-105
references.pmid: 20400885
references.citation: Nature. 2010 Mar 11;464(7286):224-31
references.pmid: 20220841
references.citation: Curr Opin HIV AIDS. 2009 Jul;4(4):247-52
references.pmid: 19532060
references.citation: N Engl J Med. 2008 Aug 28;359(9):888-90
references.pmid: 18753644
references.citation: J Virol. 2004 Mar;78(6):3140-4
references.pmid: 14990733
references.citation: J Infect Dis. 2009 Oct 15;200(8):1194-201
references.pmid: 19754311
references.citation: Curr Opin HIV AIDS. 2009 Sep;4(5):352-7
references.pmid: 20048697
references.citation: Nature. 2009 Oct 15;461(7266):908-15
references.pmid: 19829370
references.citation: Nat Immunol. 2009 Jan;10(1):116-125
references.pmid: 19029902
references.citation: AIDS. 2009 May 15;23(8):897-906
references.pmid: 19414990
references.citation: Nature. 2010 May 20;465(7296):350-4
references.pmid: 20445539
references.citation: Nat Rev Immunol. 2009 Oct;9(10):741-7
references.pmid: 19763148
references.citation: Science. 2009 Oct 9;326(5950):285-9
references.pmid: 19729618
references.citation: N Engl J Med. 2009 Dec 3;361(23):2209-20
references.pmid: 19843557
references.citation: PLoS Med. 2007 Dec;4(12):e348
references.pmid: 18052607
references.citation: PLoS One. 2010 Jan 20;5(1):e8805
references.pmid: 20098712
references.citation: PLoS Med. 2008 Apr 1;5(4):e81
references.pmid: 18384232
references.citation: Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7
references.pmid: 18490657
references.citation: PLoS Genet. 2009 Dec;5(12):e1000791
references.pmid: 20041166
references.citation: Science. 2010 Aug 13;329(5993):856-61
references.pmid: 20616233